287 related articles for article (PubMed ID: 32841918)
1. Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
Izzi F; Placidi F; Liguori C; Posca I; Lauretti B; Diomedi M; Pisani A; Mercuri NB; Rocchi C
J Neurol Sci; 2020 Nov; 418():117095. PubMed ID: 32841918
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacoeconomic aspects of monotherapy of focal epilepsy].
Mkrtchyan VR; Kaimovsky IL
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11. Vyp. 2):92-98. PubMed ID: 32207738
[TBL] [Abstract][Full Text] [Related]
3. Effects of lacosamide and carbamazepine on lipids in a randomized trial.
Mintzer S; Dimova S; Zhang Y; Steiniger-Brach B; De Backer M; Chellun D; Roebling R
Epilepsia; 2020 Dec; 61(12):2696-2704. PubMed ID: 33200428
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
5. Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: A cross-sectional study.
Jain S; Nair PP; Aghoram R; Wadwekar V; Wagh S; Balachandran M; Indira Priya D; Meher R; Nandwani S; Sreekumaran Nair N
Epilepsy Behav; 2021 Dec; 125():108396. PubMed ID: 34788731
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed temporal lobe epilepsy: Post hoc analysis of a randomized, double-blind trial.
Terada K; Kubota Y; Dimova S; Elmoufti S; Floricel F; Chellun D; O'Brien TJ
Seizure; 2023 Nov; 112():62-67. PubMed ID: 37769545
[TBL] [Abstract][Full Text] [Related]
8. Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
Lang N; Rothkegel H; Peckolt H; Deuschl G
Seizure; 2013 Nov; 22(9):726-30. PubMed ID: 23778157
[TBL] [Abstract][Full Text] [Related]
9. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
10. Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study.
Rocchi C; Placidi F; Liguori C; Del Bianco C; Lauretti B; Diomedi M; Pisani A; Mercuri NB; Izzi F
Sleep Med; 2018 Dec; 52():163-167. PubMed ID: 30359891
[TBL] [Abstract][Full Text] [Related]
11. Interictal cardiovascular autonomic responses in patients with epilepsy.
Isojärvi JI; Ansakorpi H; Suominen K; Tolonen U; Repo M; Myllylä VV
Epilepsia; 1998 Apr; 39(4):420-6. PubMed ID: 9578032
[TBL] [Abstract][Full Text] [Related]
12. Interictal autonomic nervous system function in patients with epilepsy.
Devinsky O; Perrine K; Theodore WH
Epilepsia; 1994; 35(1):199-204. PubMed ID: 8112246
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
14. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting.
Tateishi Y; Ishikawa N; Kobayashi Y; Izumo H; Eguchi Y; Okada S
Epilepsy Res; 2022 Nov; 187():107030. PubMed ID: 36308995
[TBL] [Abstract][Full Text] [Related]
16. Sudomotor and cardiovascular autonomic function in de novo Parkinson's disease assessed by sudoscan and cardiovascular reflexes.
Rocchi C; Cerroni R; Conti M; Lauretti B; Mercuri NB; Stefani A; Pierantozzi M
J Neurol Sci; 2021 Aug; 427():117502. PubMed ID: 34044239
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
20. Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy.
Rocchi C; Placidi F; Del Bianco C; Liguori C; Pisani A; Mercuri NB; Izzi F
Clin Auton Res; 2020 Dec; 30(6):557-562. PubMed ID: 32852663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]